Leo Groenewegen
Vorstandsvorsitzender bei NBAB, Nordic BioAnalysis AB
Aktive Positionen von Leo Groenewegen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
NBAB, Nordic BioAnalysis AB
 NBAB, Nordic BioAnalysis AB BiotechnologyHealth Technology Part of Ilya Pharma AB, NBAB, Nordic BioAnalysis AB engages in bio analytical development, validation and analysis of medicines. The company is based in Södertälje, Sweden. The Swedish company was founded in 2010. The CEO is Leo Groenewegen. NBAB was acquired by Ilya Pharma AB on April 19, 2022. | Vorstandsvorsitzender | 01.09.2022 | - |
Karriereverlauf von Leo Groenewegen
Ehemalige bekannte Positionen von Leo Groenewegen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NEXTCELL PHARMA AB | Finanzdirektor/CFO | - | - |
| Corporate Officer/Principal | - | 01.09.2019 |
Statistik
International
| Schweden | 3 |
Operativ
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NEXTCELL PHARMA AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
NBAB, Nordic BioAnalysis AB
NBAB, Nordic BioAnalysis AB BiotechnologyHealth Technology Part of Ilya Pharma AB, NBAB, Nordic BioAnalysis AB engages in bio analytical development, validation and analysis of medicines. The company is based in Södertälje, Sweden. The Swedish company was founded in 2010. The CEO is Leo Groenewegen. NBAB was acquired by Ilya Pharma AB on April 19, 2022. | Health Technology |
- Börse
- Insiders
- Leo Groenewegen
- Erfahrung
